Conjunctivitis (DBCOND0009989)
Identifiers
- Synonyms
- Pinkeye / Keratoconjunctivitis caused by Moraxella bovis (disorder) / Unspecified conjunctivitis / Conjunctivitis, unspecified / Conjunctivitis NOS / Conjunctivitis (disorder)
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Anthoxanthum odoratum An extract from Anthoxanthum odoratum used in allergy testing.No drug targets Anthoxanthum odoratum pollen An extract from Anthoxanthum odoratum pollen used in allergy testing.No drug targets Bacitracin A cyclic polypeptide antibiotic used to prevent wound infections, treat pneumonia and empyema in infants, and to treat skin and eye infections.- Alpha-2-macroglobulintarget
- Insulin-degrading enzymetarget
- C55-isoprenyl pyrophosphatetarget
- Bacitracin transport ATP-binding protein BcrAtransporter
- Bacitracin transport permease protein BCRBtransporter
- Bacitracin transport permease protein BcrCtransporter
Betamethasone A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders.- Glucocorticoid receptortarget
- Cytochrome P450 3A4enzyme
- ATP-dependent translocase ABCB1transporter
- Aromataseenzyme
- Cytochrome P450 3A5enzyme
- Cytochrome P450 3A7enzyme
- Cytochrome P450 2A6enzyme
- Cytochrome P450 1B1enzyme
- Cytochrome P450 2B6enzyme
- Cytochrome P450 2C8enzyme
- Cytochrome P450 2C9enzyme
- Cytochrome P450 2C19enzyme
- Albumincarrier
- Corticosteroid-binding globulincarrier
Chlorpheniramine A histamine-H1 receptor antagonist indicated for the management of symptoms associated with upper respiratory allergies.- Histamine H1 receptortarget
- Cytochrome P450 3A4enzyme
- Cytochrome P450 2D6enzyme
- Sodium-dependent serotonin transportertarget
- Sodium-dependent noradrenaline transportertarget
- Sodium-dependent dopamine transportertarget
- Cytochrome P450 3A5enzyme
- Cytochrome P450 3A7enzyme
- Solute carrier family 22 member 2transporter
- Solute carrier family 22 member 1transporter
Dactylis glomerata pollen An extract from Dactylis glomerata pollen used in allergy testing.No drug targets Dermatophagoides farinae An extract from Dermatophagoides farinae used in allergy testing.No drug targets Dermatophagoides pteronyssinus An extract from Dermatophagoides pteronyssinus used in allergy testing.No drug targets Dexamethasone A glucocorticoid available in various modes of administration that is used for the treatment of various inflammatory conditions, including bronchial asthma, as well as endocrine and rheumatic disorders.- Glucocorticoid receptortarget
- Annexin A1target
- Nitric oxide synthase, inducibletarget
- Nuclear receptor subfamily 0 group B member 1target
- Cytochrome P450 3A4enzyme
- Cytochrome P450 3A5enzyme
- Cytochrome P450 3A7enzyme
- Bile salt export pumptransporter
- ATP-dependent translocase ABCB1transporter
- ATP-binding cassette sub-family C member 2transporter
- Solute carrier organic anion transporter family member 1A2transporter
- Broad substrate specificity ATP-binding cassette transporter ABCG2transporter
- Steroid 17-alpha-hydroxylase/17,20 lyaseenzyme
- Cytochrome P450 1A1enzyme
- Cytochrome P450 2A6enzyme
- Cytochrome P450 2B6enzyme
- Cytochrome P450 2C19enzyme
- Cytochrome P450 2C8enzyme
- Cytochrome P450 2E1enzyme
- Cytochrome P450 3A43enzyme
- Cytochrome P450 4A11enzyme
- Nuclear receptor subfamily 1 group I member 2target
- Cytochrome P450 11B1, mitochondrialenzyme
- Albumincarrier
- 11-beta-hydroxysteroid dehydrogenase type 2enzyme
- 11-beta-hydroxysteroid dehydrogenase 1enzyme
- Organic anion transporter 3transporter
Dexchlorpheniramine A chlorpheniramine enantiomer antihistamine indicated in the treatment of sunburns, insect bites, and allergic reactions of the skin.- Cytochrome P450 2D6enzyme
Framycetin An aminoglycoside antibiotic used in various formulations and combinations with other agents to treat hemorrhoids, eye and ear infections, and to reduce nasal carriage of staphylococcus.Gramicidin D A bactericidal antibiotic used in the treatment of dermatological and ophthalmic infections.- ATP-dependent translocase ABCB1transporter
- Dihydropteroate synthasetarget
Hyaluronic acid A glycosaminoglycan used for the relief of joint pain, wound healing, ophthalmologic treatment, cosmetic treatment, and various other applications.- CD44 antigentarget
- Intercellular adhesion molecule 1target
- Hyaluronan mediated motility receptortarget
- Neurocan core proteintarget
- Versican core proteintarget
- Complement component 1 Q subcomponent-binding protein, mitochondrialtarget
- Hyaluronan and proteoglycan link protein 1target
- Hyaluronan and proteoglycan link protein 3target
- Hyaluronan-binding protein 2target
- Layilintarget
- Stabilin-2target
- Tumor necrosis factor-inducible gene 6 proteintarget
- Interphotoreceptor matrix proteoglycan 2target
- Intracellular hyaluronan-binding protein 4target
- Hyaluronidase enzymesenzyme
- ATP-binding cassette sub-family C member 5transporter
- Lymphatic vessel endothelial hyaluronic acid receptor 1target
Hydrocortisone acetate A corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses and ulcerative colitis.- Annexin A1target
- Glucocorticoid receptortarget
- Sex hormone-binding globulincarrier
- Cytochrome P450 3A4enzyme
- Cytochrome P450 3A5enzyme
- Cytochrome P450 3A7enzyme
- ATP-dependent translocase ABCB1transporter
- Solute carrier organic anion transporter family member 1A2transporter
- Broad substrate specificity ATP-binding cassette transporter ABCG2transporter
- Cytochrome P450 11B1, mitochondrialenzyme
- Cytochrome P450 11B2, mitochondrialenzyme
- Cytochrome P450 2C8enzyme
- Corticosteroid-binding globulincarrier
- 11-beta-hydroxysteroid dehydrogenase type 2target
- 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1target
- Organic anion transporter 3transporter
Lolium perenne pollen An extract from Lolium perenne pollen used in allergy testing.No drug targets Naphazoline A sympathomimetic vasoconstrictor used for the symptomatic relief of redness and itching of the eye, and nasal congestion.Ofloxacin An antibacterial agent used for the treatment of bacterial infections in many parts of the body, including the respiratory tract, kidney, skin, soft tissue, and urinary tract.- DNA gyrase subunit Atarget
- DNA topoisomerase 4 subunit Atarget
- DNA topoisomerase 2-alphatarget
- Cytochrome P450 1A2enzyme
- Organic cation/carnitine transporter 2transporter
- Multidrug resistance-associated protein 1transporter
- Solute carrier family 22 member 6transporter
- ATP-binding cassette sub-family C member 2transporter
- Solute carrier family 22 member 4transporter
- Bile salt export pumptransporter
- DNA gyrase subunit Atarget
- DNA gyrase subunit Btarget
Phleum pratense pollen An extract from Phleum pratense pollen used in allergy testing.No drug targets Poa pratensis pollen An extract from Poa pratensis pollen used in allergy testing.No drug targets Prednisolone A glucocorticoid used to treat adrenocortical insufficiency, inflammatory conditions, and some cancers.- Corticosteroid-binding globulincarrier
- Cytochrome P450 3A4enzyme
- Glucocorticoid receptortarget
- Solute carrier organic anion transporter family member 1A2transporter
- ATP-dependent translocase ABCB1transporter
- Albumincarrier
Sodium borate No FDA- or EMA-approved therapeutic indications on its own.No drug targets Sulfacetamide A sulfonamide used to treat inflammatory ocular conditions and acne vulgaris.Sulfamerazine An antibacterial agent used in the treatment of various bacterial infections, such as bronchitis, prostatitis, and urinary tract infections.- Dihydropteroate synthasetarget
- Albumincarrier
Tetracosactide A diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.Tetryzoline An alpha-adrenergic agonist used in the temporary symptomatic relief of discomfort and redness of the eyes due to minor irritations, as well as alleviate nasal congestion.Zinc phenolsulfonate An ingredient in ophthalmic solutions indicated in the treatment of minor irritation and conjunctivitis.No drug targets - Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT04397666 RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 No drug interventions other Not Available unknown_status NCT00783198 Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED) No drug interventions treatment 2 / 3 completed NCT06469697 Zanzibar Arts for Children's Eyesight Pilot Trial No drug interventions prevention Not Available active_not_recruiting NCT01385371 A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) No drug interventions treatment 3 completed NCT00581542 Moxifloxacin vs. Polytrim for Conjunctivitis treatment 4 completed NCT00567918 Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis treatment 3 completed NCT04984941 Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients No drug interventions Not Available Not Available completed NCT00001734 Screening for NEI Clinical Studies No drug interventions Not Available Not Available completed NCT03519516 Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects treatment 1 completed NCT01600365 Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus treatment 3 unknown_status NCT02795273 Efficacy and Safety of Grass-SPIRE Registration Study No drug interventions treatment 2 / 3 withdrawn NCT04346160 A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease No drug interventions Not Available Not Available unknown_status NCT00567762 Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis treatment 3 completed NCT00550550 Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) treatment 3 completed NCT03631108 Feasibility Study and Preliminary Application Study on Iris OCTA No drug interventions Not Available Not Available unknown_status NCT00857779 Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients No drug interventions treatment 2 completed NCT06229379 The Effects of a Large Language Model on Clinical Questioning Skills No drug interventions other Not Available recruiting NCT03753893 Ocular Manifestations in Rheumatic Diseases No drug interventions Not Available Not Available completed NCT04374656 Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic No drug interventions Not Available Not Available completed NCT02503956 Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients No drug interventions treatment Not Available completed NCT00770315 Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) No drug interventions treatment 2 / 3 completed NCT06092515 Efficacy of Zinc Fortified Fermented Wheat Flour No drug interventions prevention Not Available completed NCT00522600 Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations No drug interventions Not Available Not Available completed NCT00705159 Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis treatment 4 completed NCT00562159 Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) treatment 3 completed NCT04709575 Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis treatment 3 completed NCT05430919 Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conjunctivitis Symptoms and Skin Test Reactivity Upon Exposure to Birch Allergen in Adult Participants treatment 2 completed NCT00008541 Evaluation and Treatment of Patients With Corneal and External Diseases No drug interventions Not Available Not Available completed NCT04837534 Improving the Follow up Rate for Pediatric Patients No drug interventions health_services_research Not Available completed NCT01028027 Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis treatment 3 completed NCT00978029 Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) No drug interventions treatment 2 completed NCT00623701 Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation No drug interventions treatment 3 completed NCT00732446 Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis treatment 3 completed NCT00921895 A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis No drug interventions diagnostic Not Available completed NCT02472223 Reducing Adenoviral Patient Infected Days treatment Not Available completed NCT04287608 Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis Not Available Not Available completed